Johns Hopkins University Researchers published a study in 2017 in JAMA that revealed 58 out of 84 CBD products purchased online were mislabeled. In order to provide the market with some transparency, we created Canodyne to offer our Health Care Providers a trusted, affordable solution to treat their patients’ pain.
Health Care Provider FAQs
Canodyne is a topical pain relief gel that is uniquely formulated to combine natural, organic healing compounds with clinically proven pharmaceutical pain relievers.
CBD (Cannabidiol) is one of over 120 organic chemical compounds found in Hemp, a member of the Cannabis Sativa family. Unlike its cannabinoid cousin Delta-9 THC and other pharmaceutical opioids, CBD delivers therapeutic benefits without the undesirable side effects.
CBD is Non-Euphoric, Non-Toxic, and Non-Habit Forming.
A vast network of receptors throughout the human body known as the Endocannabinoid System (ES) reacts to CBD to regulate many physiological processes including pain modulation. A 2015 study revealed that when used topically, CBD had the potential to fight pain and inflammation.
President Trump signed the Agriculture Improvement Act of 2018 (popularly known as the 2018 Farm Bill) into law on December 20, 2018. Among the 2018 Farm Bill’s broad-ranging provisions, it legalizes the cultivation and sale of hemp at the federal level, effective January 1, 2019.